An Open Label, Single-Center, Pilot Trial of the Combination of Tagraxofusp TAG with Pacritinib PAC in Patients with Intermediate-1 or Higher Myelofibrosis MF, Who Have had Prior Therapy with the Approved JAK1/2 Inhibitors or in Which Therapy with the Approved JAK1/2 Inhibitors is Not Appropriate, Contraindicated or Declined by the Subjects
A Phase 3 Trial Investigating Blinatumomab NSC 765986 in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia B-ALL and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma B-LLy
A phase II trial of tisagenlecleucel in first-line high-risk HR pediatric and young adult patients with B-cell acute lymphoblastic leukemia B-ALL who are minimal residual disease MRD positive at the end of consolidation EOC therapy
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones
A Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive Ph+ Acute Lymphoblastic Leukemia ALL Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation
ENCERT: A Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Relapsed T Cell Lymphoblastic Leukemia/Lymphoma